| Authors: |
Giani C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Denu RA; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA., Ljevar S; Department of Clinical Epidemiology and Trial Organisation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gronchi A; Department of Sarcoma Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Napolitano A; Department of Medical Oncology, The Royal Marsden NHS, London, UK., Rosenbaum E; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Salawu A; Division of Medical Oncology and Hematology, Mount Sinai Hospital and Princess Margaret Cancer Centre, Toronto, Canada., Bajpai J; Department of Medical Oncology, Tata Memorial Centre, Homibhabha National University, Mumbai, India., Connolly EA; Central Clinical School, Faculty of Medicine and Health Science, The University of Sydney, Sydney, Australia., Lee ATJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, UK., Trent JC; Department of Medical Oncology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, USA., Koseła-Paterczyk H; Department of Medical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Chia-Chen Li Z; Department of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan., Ogura K; Department of Musculoskeletal Oncology, National Cancer Center Hospital, Tokyo, Japan., Palmerini E; Department of Medical Oncology, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy., Baldi GG; Department of Medical Oncology, Hospital of Prato, Azienda USL Toscana Centro, Prato, Italy., Brunello A; Department of Oncology, Medical Oncology 1 Unit, Istituto Oncologico Veneto IOV - IRCCS, Padua, Italy., Campos F; Department of Medical Oncology, A.C.Camargo Cancer Center, São Paulo, Brazil., Cicala CM; Department of Medical Oncology, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Maki RG; Department of Medical Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, USA., Wagner AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA., Andelkovic V; Department of Medical Oncology, Princess Alexandra Hospital (PAH), Woolloongabba, Australia., Loong HH; Department of Clinical Oncology, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong SAR, China., Wong DD; Department of Anatomical Pathology, PathWest, Sir Charles Gairdner Hospital, Perth, Australia., Jones RL; Department of Medical Oncology, The Royal Marsden NHS, London, UK., Tap WD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA., Taverna SM; Technology Transfer Office, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lazar AJ; Department of Pathology and Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, USA., Demicco EG; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital and Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada., Hong A; Central Clinical School, Faculty of Medicine and Health Science, The University of Sydney, Sydney, Australia., Bovee JVMG; Department of Pathology, Leiden University Medical Center (LUMC), Leiden, The Netherlands., Dei Tos AP; Department of Pathology, Azienda Ospedale-Università Padova, Padova, Italy., Fletcher CDM; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, USA., Baumhoer D; Department of Pathology, University Hospital Basel, Basel, Switzerland., Sbaraglia M; Department of Pathology, Azienda Ospedale-Università Padova, Padova, Italy., Schaefer IM; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, USA., Miceli R; Department of Clinical Epidemiology and Trial Organisation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Stacchiotti S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: silvia.stacchiotti@istitutotumori.mi.it. |
